Word

MYALL

Status

Dead

Status Code

606

Status Date

Monday, September 6, 2021

Serial Number

87806761

Mark Type

4000

Filing Date

Thursday, February 22, 2018

Published for Opposition

Tuesday, June 5, 2018

Abandoned Date

Monday, September 6, 2021

Trademark Owner History

INVIVOSCRIBE, INC. - 1st New Owner After Publication
Invivoscribe Technologies, Inc. - Owner At Publication

Classifications

1 Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use

5 Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids

42 DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays

44 DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays

Trademark Events

Sep 7, 2021

Abandonment Notice E-Mailed - No Use Statement Filed

Sep 6, 2021

Abandonment - No Use Statement Filed

Feb 10, 2021

Notice Of Approval Of Extension Request E-Mailed

Feb 9, 2021

Extension 5 Granted

Jan 25, 2021

Extension 5 Filed

Feb 9, 2021

Case Assigned To Intent To Use Paralegal

Jan 25, 2021

Teas Extension Received

Aug 1, 2020

Notice Of Approval Of Extension Request E-Mailed

Jul 30, 2020

Extension 4 Granted

Jul 30, 2020

Extension 4 Filed

Jul 30, 2020

Teas Extension Received

Jan 21, 2020

Notice Of Approval Of Extension Request E-Mailed

Jan 17, 2020

Extension 3 Granted

Jan 17, 2020

Extension 3 Filed

Jan 17, 2020

Teas Extension Received

Jul 4, 2019

Notice Of Approval Of Extension Request E-Mailed

Jul 2, 2019

Extension 2 Granted

Jul 2, 2019

Extension 2 Filed

Jul 2, 2019

Teas Extension Received

Jan 30, 2019

Notice Of Approval Of Extension Request E-Mailed

Jan 28, 2019

Extension 1 Granted

Jan 28, 2019

Extension 1 Filed

Jan 28, 2019

Teas Extension Received

Sep 5, 2018

Automatic Update Of Assignment Of Ownership

Jul 31, 2018

Noa E-Mailed - Sou Required From Applicant

Jun 5, 2018

Official Gazette Publication Confirmation E-Mailed

Jun 5, 2018

Published For Opposition

May 16, 2018

Notification Of Notice Of Publication E-Mailed

Apr 28, 2018

Approved For Pub - Principal Register

Apr 28, 2018

Assigned To Examiner

Feb 28, 2018

New Application Office Supplied Data Entered In Tram

Feb 26, 2018

New Application Entered In Tram